Companies: 11,345     total market cap: โ‚น14729.314 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Repligen
RGEN
#1955
Rank
โ‚น994.03 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
โ‚น15,656
Share price
-3.25%
Change (1 day)
20.85%
Change (1 year)
๐Ÿงฌ Biotech
Categories

Revenue for Repligen (RGEN)

Revenue in 2026 (TTM): โ‚น72.07 Billion

According to Repligen 's latest financial reports the company's current revenue (TTM ) is โ‚น75.97 Billion. In 2025 the company made a revenue of โ‚น66.27 Billion an increase over the revenue in the year 2024 that were of โ‚น54.42 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Repligen from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น72.07 B8.76%
2025 โ‚น66.27 B21.77%
2024 โ‚น54.42 B5.2%
2023 โ‚น51.73 B-22%
2022 โ‚น66.32 B32.9%
2021 โ‚น49.90 B86.32%
2020 โ‚น26.78 B38.99%
2019 โ‚น19.27 B42.04%
2018 โ‚น13.56 B50.44%
2017 โ‚น9.01 B26.94%
2016 โ‚น7.10 B27.97%
2015 โ‚น5.55 B37.84%
2014 โ‚น4.02 B-4.37%
2013 โ‚น4.21 B23.53%
2012 โ‚น3.40 B
2010 โ‚น1.17 B22.54%
2009 โ‚น0.96 B-28.83%
2008 โ‚น1.34 B74.55%
2007 โ‚น0.77 B31.6%
2006 โ‚น0.58 B0.24%
2005 โ‚น0.58 B59.56%
2004 โ‚น0.36 B17.77%
2003 โ‚น0.31 B-10.27%
2002 โ‚น0.34 B98.35%
2001 โ‚น0.17 B40.2%
2000 โ‚น0.12 B-16.48%
1999 โ‚น0.14 B46.61%
1998 โ‚น0.10 B-10.46%
1997 โ‚น0.11 B-16.57%
1996 โ‚น0.13 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚น6.163 T 8,012.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น4.483 T 5,801.92%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น4.900 T 6,349.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.759 T 6,165.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น3.34 B-95.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น40.04 B-47.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น326.49 B 329.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น117.57 B 54.76%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น329.65 B 333.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
โ‚น386.98 B 409.36%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com